Danish cancer vaccine patented in the US

Adaptvac, a joint venture between a Copenhagen University spinout and Danish Expres2ion, has taken out a patent in the US on a new breast cancer vaccine. "An important milestone," says the chairman.

Photo: Colourbox

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles